Abstract
Background
The study aimed to investigate the potential risk factors for the placenta accreta spectrum (PAS), determine the predictive value of a diagnostic model, and evaluate the effects of octamethylcyclotetrasiloxane (OMCTS) on trophoblast proliferation and migration.
Methods
This case–control study included 244 pregnant women with PAS and 327 normal pregnant women who visited Guangzhou Women and Children’s Medical Centre, China, from January 2014 to December 2017. Blood was collected from 42 women with PAS and 77 controls, and plasma specimens were analyzed by gas chromatography–time-of-flight mass spectrometry. In addition, the proliferation and migration of trophoblast cells were examined after treatment with OMCTS.
Results
We found an association between the risk of PAS and clinical factors related to fasting blood glucose levels (BS0, OR = 5.78), as well as factors related to endometrial injury [history of cesarean section (OR = 179.59), uterine scarring (OR = 68.37), and history of abortion (OR = 5.66)]. Equally important, pregnant women with PAS had significantly higher plasma OMCTS concentrations than controls. In vitro, we found that OMCTS could promote the proliferation and migration of HTR8/SVneo cells. The model of combining clinical factors and OMCTS had a good performance in PAS prediction (AUC = 0.97, 95% CI 0.78–0.93).
Conclusions
The early diagnosis of PAS in pregnant women requires assessing risk factors, metabolic status, and BS0 levels before 20 weeks of gestation. OMCTS may be related to the development of PAS by promoting trophoblast cell proliferation and migration.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
Code availability
Not applicable.
References
Jeal N, Salisbury C (2007) Health needs and service use of parlour-based prostitutes compared with street-based prostitutes: A cross-sectional survey. BJOG: An International Journal of Obstetrics and Gynaecology 114 (7):875–881. doi:https://doi.org/10.1111/j.1471-0528.2007.01379.x
Jauniaux E, Ayres-de-Campos D, Duncombe G, Klaritsch P, Chantraine F, Kingdom J, Grønbeck L, Rull K, Nigatu B, Tikkanen M, Sentilhes L, Asatiani T, Leung WC, Aihaidari T, Brennan D, Kondoh E, Yang JI, Seoud M, Jegasothy R, Espino y Sosa S, Jacod B, D’Antonio F, Shah N, Bomba-Opon D, Ayres-de-Campos D, Jeremic K, Kok TL, Soma-Pillay P, Tul Mandić N, Lindqvist P, Arnadottir TB, Hoesli I, Jaisamrarn U, Al Mulla A, Robson S, Cortez R (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. International Journal of Gynecology and Obstetrics 140 (3):261-264. doi:https://doi.org/10.1002/ijgo.12406
Cheng KKN, Lee MMH (2015) Rising incidence of morbidly adherent placenta and its association with previous caesarean section: a 15-year analysis in a tertiary hospital in Hong Kong. Hong Kong Med J 21(6):511–517. https://doi.org/10.12809/hkmj154599
Chiu TL, Sadler L, Wise MR (2013) Placenta praevia after prior caesarean section: an exploratory case-control study. Aust N Z J Obstet Gynaecol 53(5):455–458. https://doi.org/10.1111/ajo.12098
Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnadóttir RI, Tapper AM, Børdahl PE, Gottvall K, Petersen KB, Krebs L, Gissler M, Langhoff-Roos J, Källen K (2016) Abnormally invasive placenta—prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG: an International Journal of Obstetrics and Gynaecology 123 (8):1348–1355. https://doi.org/10.1111/1471-0528.13547
Accreta P (2011) Committee opinion Placenta Accreta the American college of obstetricians and gynecologists. Obstet Gynecol 118(501):405–410
Meng X, Xie L, Song W (2013) Comparing the diagnostic value of ultrasound and magnetic resonance imaging for placenta accreta: a systematic review and meta-analysis. Ultrasound Med Biol 39(11):1958–1965. https://doi.org/10.1016/j.ultrasmedbio.2013.05.017
Zosmer N, Fuller J, Shaikh H, Johns J, Ross JA (2015) Natural history of early first-trimester pregnancies implanted in Cesarean scars. Ultrasound Obstet Gynecol 46(3):367–375. https://doi.org/10.1002/uog.14775
Desai N, Krantz D, Roman A, Fleischer A, Boulis S, Rochelson B (2014) Elevated first trimester PAPP-A is associated with increased risk of placenta accreta. Prenat Diagn 34(2):159–162. https://doi.org/10.1002/pd.4277
Thompson O, Otigbah C, Nnochiri A, Sumithran E, Spencer K (2015) First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation. BJOG: an International Journal of Obstetrics and Gynaecology 122 (10):1370–1376. doi:https://doi.org/10.1111/1471-0528.13298
Wang R, Moody RP, Koniecki D, Zhu J (2009) Low molecular weight cyclic volatile methylsiloxanes in cosmetic products sold in Canada: implication for dermal exposure. Environ Int 35(6):900–904. https://doi.org/10.1016/j.envint.2009.03.009
Biesterbos JWH, Beckmann G, van Wel L, Anzion RBM, von Goetz N, Dudzina T, Roeleveld N, Ragas AMJ, Russel FGM, Scheepers PTJ (2015) Aggregate dermal exposure to cyclic siloxanes in personal care products: implications for risk assessment. Environ Int 74:231–239. https://doi.org/10.1016/j.envint.2014.10.017
Siddiqui WH, Stump DG, Plotzke KP, Holson JF, Meeks RG (2007) A two-generation reproductive toxicity study of octamethylcyclotetrasiloxane (D4) in rats exposed by whole-body vapor inhalation. Reprod Toxicol 23(2):202–215. https://doi.org/10.1016/j.reprotox.2006.11.011
Jean PA, Plotzke KP (2017) Chronic toxicity and oncogenicity of octamethylcyclotetrasiloxane (D4) in the Fischer 344 rat. Toxicol Lett 279:75–97. https://doi.org/10.1016/j.toxlet.2017.06.003
Franzen A, Greene T, Van Landingham C, Gentry R (2017) Toxicology of octamethylcyclotetrasiloxane (D4). Toxicol Lett 279(April):2–22. https://doi.org/10.1016/j.toxlet.2017.06.007
Laíns I, Gantner M, Murinello S, Lasky-Su JA, Miller JW, Friedlander M, Husain D (2019) Metabolomics in the study of retinal health and disease. Prog Retin Eye Res 69:57–79. https://doi.org/10.1016/j.preteyeres.2018.11.002
Cali G, Forlani F, Timor-Tritsch IE, Palacios-Jaraquemada J, Minneci G, D’Antonio F (2017) Natural history of Cesarean scar pregnancy on prenatal ultrasound: the crossover sign. Ultrasound Obstet Gynecol 50(1):100–104. https://doi.org/10.1002/uog.16216
Jurkovic D (2014) Cesarean scar pregnancy and placenta accreta. Ultrasound Obstet Gynecol 43(4):361–362. https://doi.org/10.1002/uog.13346
Roberge S, Demers S, Berghella V, Chaillet N, Moore L, Bujold E (2014) Impact of single- vs double-layer closure on adverse outcomes and uterine scar defect: a systematic review and metaanalysis. Am J Obstet Gynecol 211(5):453–460. https://doi.org/10.1016/j.ajog.2014.06.014
Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM (2014) Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol 31(9):799–804. https://doi.org/10.1055/s-0033-1361833
Eshkoli T, Weintraub AY, Sergienko R, Sheiner E (2013) Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol 208(3):219.e211-219.e217. https://doi.org/10.1016/j.ajog.2012.12.037
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M (2014) The management and outcomes of placenta accreta, increta, and percreta in the UK: A population-based descriptive study. BJOG: An International Journal of Obstetrics and Gynaecology 121 (1):62–71. doi:https://doi.org/10.1111/1471-0528.12405
Balayla J, Bondarenko HD (2013) Placenta accreta and the risk of adverse maternal and neonatal outcomes. J Perinat Med 41(2):141–149. https://doi.org/10.1515/jpm-2012-0219
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M (2012) Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study. PLoS One 7 (12). doi:https://doi.org/10.1371/journal.pone.0052893
Klar M, Laub M, Schulte-Moenting J, Proempeler H, Kunze M (2013) Clinical risk factors for complete and partial placental retention -a case-control study. J Perinat Med 41(5):529–534. https://doi.org/10.1515/jpm-2012-0260
Morlando M, Sarno L, Napolitano R, Capone A, Tessitore G, Maruotti GM, Martinelli P (2013) Placenta accreta: Incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand 92(4):457–460. https://doi.org/10.1111/aogs.12080
Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, TsTa H (1999) Risk factors for placenta accreta. Obstet Gynecol 93(4 SUPPL.):545–550. https://doi.org/10.1097/00006250-199904000-00015
Acknowledgements
We thank the International Science Editing (http://www.internationalscienceediting.com) for editing this manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (grant number: 81871716), the Natural Science Foundation of Guangdong Province (grant number: 2018A0303130314), and the Science and Technology Foundation of Guangzhou (grant numbers: 201704020109, 201707010019, and 201707010497). National Natural Science Foundation of China, 81871716, Hongling Yang, Natural Science Foundation of Guangdong Province, 2018A0303130314, Yan Long, Guizhou Science and Technology Department, 201704020109, Yan Long, 201707010019, Hongling Yang, 201707010497, Chunyan Zhu
Author information
Authors and Affiliations
Contributions
YL and HY conceived and directed the study; MJ, FG XD, and YL performed the analysis and visualization; MJ, MH, QG, FZ, SZ, and WY collected the samples; YL drafted the manuscript; and YH, HY, and CZ revised the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethics approval
Not applicable.
Consent to participate
The authors agreed to participate in this study.
Consent for publication
The authors agreed to publish this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Long, Y., Jiang, M., Gao, F. et al. The potential risk factors of placenta increta and the role of octamethylcyclotetrasiloxane. Arch Gynecol Obstet 306, 723–734 (2022). https://doi.org/10.1007/s00404-021-06335-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-021-06335-w